12:24:11 EDT Mon 29 May 2023
Enter Symbol
or Name

Login ID:

Cannabis Summary for Sept. 21, 2022

2022-09-21 19:59 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The S&P/TSX Cannabis Index lost 1.27 to 38.88, while the CSE Composite Index lost 1.47 to 267.92. Canadian cannabis grower Aurora Cannabis Inc. (ACB) lost 14 cents to $1.74 on 7.57 million shares, as it lived up to its quarterly tradition of releasing disappointing financials. The latest batch included a painful net loss of $618-million for the fiscal fourth quarter ended June 30.

The pain did not end there. Revenue in the fourth quarter came to $50.2-million, a decrease (if a small one) from $50.4-million in the third quarter. The decrease would have been worse if not for eight weeks of contributions from the takeover in May of Thrive Cannabis. The steep net loss of $618-million included $505-million in impairments that Aurora blamed on "changes in cannabis market conditions and in the current capital market environment." Even after sweeping those and many other pesky costs and charges to the side, adjusted EBITDA worsened quarter over quarter to negative $12.9-million from negative $11.4-million.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2023 Canjex Publishing Ltd. All rights reserved.

Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.